Dexmedetomidine sedation for transesophageal echocardiography during percutaneous atrial septal defect closure in adult

Atrial septal defect (ASD) is second common congenital heart disease that often leads to adult period. Intracardiac or transesophageal echocardiography (TEE) is essential for percutaneous closure of ASD using Amplatzer septal occluder. Dexmedetomidine (DEX), which is a highly selective α(2)-agonist,...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Jae Wook, Cheol Go, Gwang, Jeon, Sang Yoon, Bang, Sira, Lee, Ki Hwa, Kim, Yong Han, Kim, Dong-Kie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publicaitons 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905376/
https://www.ncbi.nlm.nih.gov/pubmed/24550975
Descripción
Sumario:Atrial septal defect (ASD) is second common congenital heart disease that often leads to adult period. Intracardiac or transesophageal echocardiography (TEE) is essential for percutaneous closure of ASD using Amplatzer septal occluder. Dexmedetomidine (DEX), which is a highly selective α(2)-agonist, has sedative and analgesic properties without respiratory depression in the clinical dose range. We report percutaneous closure of ASD with TEE under DEX sedation.

Ejemplares similares